Private equity firms are increasingly returning to the European high-yield debt markets to extract dividends from portfolio companies, as elevated volatility and a subdued exit environment continue to delay traditional monetisation routes such as M&A and IPOs, according to a report by Bloomberg.
Sponsor-backed borrowers including Brookfield Asset Management-linked REIT Befimmo, Lutech, and Cooper Consumer Health—the latter backed by a consortium including CVC Capital Partners—have recently e...
Continue Reading
Sign up for FREE to read the full article and access 131K+ alternative investment headlines.